In Vitro Fertilization (IVF) Hormones Market Analysis

The in vitro fertilization (IVF) hormones market is thriving primarily on account of the growing demand for IVF procedures, which has spiked significantly in the last few years, backed by the increasing incidences of infertility and therefore the need amongst individuals to undergo an IVF procedure. IVF has emerged as a revolutionary technique that helps couples to have their own child y allowing the fertilization procedure outside the body. IVF hormones help to catalyze the process by stimulating the production of eggs or sperms in women and men respectively. The market is segmented by type into follicle-stimulating hormone (FSH)/gonadotropin-releasing hormone agonist (GnRH), and luteinizing hormone (LH). Among these segments, the follicle-stimulating hormone (FSH) segment is anticipated to hold the largest market share by the end of 2021. The growth of the segment can be attributed primarily to the ability of the hormone to stimulate the growth of the small follicles which increases the success rate of pregnancy through IVF, along with the high preference of the healthcare practitioners for the utilization of FSH.

Our in-depth analysis of the global market includes the following segments: